Skip to Main Content

Paper Details

Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
Eur J Heart Fail
1
2024
ACE, Heart Failure, LVSD, MI, MRA, Patients, Sacubitril, angiotensin receptor, cardiovascular death, congestion, heart failure, hyperkalaemia, hypotension, left ventricular systolic dysfunction, mineralocorticoid receptor, myocardial infarction, neprilysin, patients, post-myocardial infarction, pulmonary congestion, ramipril, sacubitril, valsartan
Author NameAffiliation
Gerasimos FilippatosNational and Kapodistrian University of Athens, Attikon University Hospital
Eugene BraunwaldBrigham and Women's Hospital, and Harvard Medical School Boston
  • 1 - 2

Datasets

Release 1.2